Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience.

Authors

Angelena Crown
Elizabeth Carlson
Flavio G Rocha
Janie Grumley, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USAFollow

Document Type

Article

Publication Date

12-1-2020

Publication Title

The breast journal

Abstract

Intraoperative radiation therapy (IORT) has been shown to reduce local recurrence rates among women with early-stage invasive ductal carcinoma, but data regarding its use among women with in situ carcinoma are limited. In this single-institution study, 50 women with in situ carcinoma were treated with oncoplastic breast-conserving surgery (OPS) and single-dose IORT. All 50 patients had "no tumor on ink," but 9 (16%) had margins < 2 mm and required additional therapy. No local recurrences were observed after a median follow-up of 46 months. Single-dose IORT is an efficacious treatment for well-selected patients with DCIS.

Clinical Institute

Cancer

Clinical Institute

Women & Children

Department

Oncology

Recommended Citation

Crown, Angelena; Carlson, Elizabeth; Rocha, Flavio G; and Grumley, Janie, "Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience." (2020). Articles, Abstracts, and Reports. 4136.
https://digitalcommons.providence.org/publications/4136